Breast reduction: safe in the morbidly obese?

Area of Science:

• Plastic Surgery
• Obesity Medicine

Background:

• Increasing prevalence of obesity leads to more women seeking large breast reductions (gigantomastia).
• Limited data exists on outcomes for morbidly obese patients undergoing reduction mammaplasty.
• Previous studies suggest higher complication rates in obese women undergoing large-volume breast reductions.

Purpose of the Study:

• To investigate the influence of reduction mass, age, body mass index (BMI), smoking, surgical technique, and comorbidities on complication rates in reduction mammaplasty.
• To determine if patient characteristics and surgical factors affect outcomes in obese and morbidly obese patients.

Main Methods:

• Retrospective analysis of 179 reduction mammaplasty patients.
• Patients categorized by reduction size, age, and BMI.
• Complication rates analyzed against reduction mass, age, BMI, smoking status, surgical method, and comorbidities.

Main Results:

• Overall complication rate was 50%.
• No statistical difference in complications based on reduction size, age, or BMI.
• Surgical method, smoking status, and comorbidities did not significantly impact complication rates.

Conclusions:

• Large-volume breast reductions in morbidly obese patients with comorbidities are as safe as in other patient populations.
• Patient factors such as BMI and comorbidities do not significantly increase complication risks for reduction mammaplasty.